When John Nuslein began experiencing chest pain, he contacted his doctor and underwent a round of tests. But the standard electrocardiogram and cardiac treadmill were inconclusive. It took a nuclear medicine stress test — a procedure in which a radioactive substance is injected into a vein — to visualize two blocked arteries in his heart. Since then, the 66-year-old man from Albany, Oregon, has undergone multiple heart procedures.
A group of researchers in the College of Engineering, however, are working with teams of undergraduate and graduate students on a project that may soon have the whole world talking about sepsis. Finally there may be a way to combat this syndrome with something other than antibiotics — which often don’t work.
When dying people choose to hasten death with a doctor’s help, their caregivers often face a troubling dilemma. In particular, hospice — the final stop for many terminal patients — poses an overlooked problem, OSU researchers report. That’s because hospice objects to physician-assisted death, yet most patients who choose assisted death are in hospice care.
Viviana Perez, an assistant professor in the Department of Biochemistry and Biophysics at Oregon State, seeks to generate new insights into human aging through the study of protein homeostasis, dietary restriction and an immunosuppressant drug called rapamycin.
When flu season rolls around, hundreds of thousands of Americans will get sick. Nearly a quarter-million will be hospitalized. Tens of thousands will die.
On average, an individual encounters about 80,000 synthetic chemicals every day. So says Robert Tanguay, a toxicologist at Oregon State University. Many of those chemicals — from fire retardants in fabrics to drying agents in paint — are untested for toxicity to people. Tanguay and his research team are working to change that. Their results are helping those who make the products we use as well as those who use them.